Sumitomo Pharma Switzerland GmbH

Clinical trials sponsored by Sumitomo Pharma Switzerland GmbH, explained in plain language.

Now part of Sumitomo Pharma Co., Ltd. 4506 TOKYO

Swiss subsidiary of Sumitomo Pharma, focusing on pharmaceutical development and commercialization.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.

Completed 1

New birth control pill aims to help women with painful conditions

Disease control Completed

This study tested whether a daily combination pill (relugolix, estradiol, and norethindrone acetate) can prevent pregnancy in women aged 18 to 50 who have uterine fibroids or endometriosis. Over 1,100 women took the pill for up to a year, and researchers counted how many became p…

Phase 3 • Sponsor: Sumitomo Pharma Switzerland GmbH • Aim: Disease control

Last updated Jun 27, 2026 12:33 UTC

Sumitomo Pharma Switzerland GmbH

New birth control pill aims to help women with painful conditions